176 related articles for article (PubMed ID: 18805004)
1. Synthesis and biological activity of enantiomeric pairs of 5-[(E)-cycloalk-2-enylidenemethyl]thiolactomycin congeners.
Ohata K; Terashima S
Bioorg Med Chem Lett; 2008 Oct; 18(20):5598-600. PubMed ID: 18805004
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activity of enantiomeric pairs of 5-vinylthiolactomycin congeners.
Ohata K; Terashima S
Bioorg Med Chem Lett; 2007 Jul; 17(14):4070-4. PubMed ID: 17507223
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of enantiomeric pairs of 5-(Alk-2-enyl)thiolactomycin and 5-[(E)-Cycloalk-2-enylidenemethyl]thiolactomycin congeners.
Ohata K; Terashima S
Chem Pharm Bull (Tokyo); 2009 Sep; 57(9):920-36. PubMed ID: 19721252
[TBL] [Abstract][Full Text] [Related]
4. Novel fatty acid synthase (FAS) inhibitors: design, synthesis, biological evaluation, and molecular docking studies.
Wang X; Lin J; Chen Y; Zhong W; Zhao G; Liu H; Li S; Wang L; Li S
Bioorg Med Chem; 2009 Mar; 17(5):1898-904. PubMed ID: 19223187
[TBL] [Abstract][Full Text] [Related]
5. Application of a flexible synthesis of (5R)-thiolactomycin to develop new inhibitors of type I fatty acid synthase.
McFadden JM; Medghalchi SM; Thupari JN; Pinn ML; Vadlamudi A; Miller KI; Kuhajda FP; Townsend CA
J Med Chem; 2005 Feb; 48(4):946-61. PubMed ID: 15715465
[TBL] [Abstract][Full Text] [Related]
6. Discovery and SAR of benzyl phenyl ethers as inhibitors of bacterial phenylalanyl-tRNA synthetase.
Montgomery JI; Toogood PL; Hutchings KM; Liu J; Narasimhan L; Braden T; Dermyer MR; Kulynych AD; Smith YD; Warmus JS; Taylor C
Bioorg Med Chem Lett; 2009 Feb; 19(3):665-9. PubMed ID: 19121937
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel tricyclic oxazolidinones by a tandem SN2 and SNAr reaction: SAR studies on conformationally constrained analogues of Linezolid.
Selvakumar N; Yadi Reddy B; Sunil Kumar G; Khera MK; Srinivas D; Sitaram Kumar M; Das J; Iqbal J; Trehan S
Bioorg Med Chem Lett; 2006 Aug; 16(16):4416-9. PubMed ID: 16781153
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antifungal activity of 6-arylamino-phthalazine-5,8-diones and 6,7-bis(arylthio)-phthalazine-5,8-diones.
Ryu CK; Park RE; Ma MY; Nho JH
Bioorg Med Chem Lett; 2007 May; 17(9):2577-80. PubMed ID: 17320386
[TBL] [Abstract][Full Text] [Related]
9. Discovery of new Gram-negative antivirulence drugs: structure and properties of novel E. coli WaaC inhibitors.
Moreau F; Desroy N; Genevard JM; Vongsouthi V; Gerusz V; Le Fralliec G; Oliveira C; Floquet S; Denis A; Escaich S; Wolf K; Busemann M; Aschenbrenner A
Bioorg Med Chem Lett; 2008 Jul; 18(14):4022-6. PubMed ID: 18571407
[TBL] [Abstract][Full Text] [Related]
10. Discovery of bacterial fatty acid synthase inhibitors from a Phoma species as antimicrobial agents using a new antisense-based strategy.
Ondeyka JG; Zink DL; Young K; Painter R; Kodali S; Galgoci A; Collado J; Tormo JR; Basilio A; Vicente F; Wang J; Singh SB
J Nat Prod; 2006 Mar; 69(3):377-80. PubMed ID: 16562839
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: synthesis and SAR studies.
Lin X; Murray JM; Rico AC; Wang MX; Chu DT; Zhou Y; Del Rosario M; Kaufman S; Ma S; Fang E; Crawford K; Jefferson AB
Bioorg Med Chem Lett; 2006 Aug; 16(16):4163-8. PubMed ID: 16765046
[TBL] [Abstract][Full Text] [Related]
12. 1-Oxo-3-substitute-isothiochroman-4-carboxylic acid compounds: synthesis and biological activities of FAS inhibition.
Wang X; Zhao G; Chen Y; Xu X; Zhong W; Wang L; Li S
Bioorg Med Chem Lett; 2009 Feb; 19(3):770-2. PubMed ID: 19097781
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel C (7) modified chrysin analogues as antibacterial agents.
Suresh Babu K; Hari Babu T; Srinivas PV; Hara Kishore K; Murthy US; Rao JM
Bioorg Med Chem Lett; 2006 Jan; 16(1):221-4. PubMed ID: 16213726
[TBL] [Abstract][Full Text] [Related]
14. [1,2,3]Triazolo[4,5-h]quinolones. A new class of potent antitubercular agents against multidrug resistant Mycobacterium tuberculosis strains.
Carta A; Palomba M; Paglietti G; Molicotti P; Paglietti B; Cannas S; Zanetti S
Bioorg Med Chem Lett; 2007 Sep; 17(17):4791-4. PubMed ID: 17604166
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activities of reveromycin A and spirofungin A derivatives.
Shimizu T; Usui T; Fujikura M; Kawatani M; Satoh T; Machida K; Kanoh N; Woo JT; Osada H; Sodeoka M
Bioorg Med Chem Lett; 2008 Jul; 18(13):3756-60. PubMed ID: 18519164
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of platensimycin analogs.
Shen HC; Ding FX; Singh SB; Parthasarathy G; Soisson SM; Ha SN; Chen X; Kodali S; Wang J; Dorso K; Tata JR; Hammond ML; Maccoss M; Colletti SL
Bioorg Med Chem Lett; 2009 Mar; 19(6):1623-7. PubMed ID: 19233644
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial activities of novel oxazolidinones having spiro[2,4]heptane moieties.
Kim SY; Park HB; Cho JH; Yoo KH; Oh CH
Bioorg Med Chem Lett; 2009 May; 19(9):2558-61. PubMed ID: 19345578
[TBL] [Abstract][Full Text] [Related]
18. Phenylimidazole derivatives as new inhibitors of bacterial enoyl-ACP reductase FabK.
Kitagawa H; Ozawa T; Takahata S; Iida M
Bioorg Med Chem Lett; 2007 Sep; 17(17):4982-6. PubMed ID: 17600706
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of 3,6-bicyclolides: a novel class of macrolide antibiotics.
Gai Y; Tang D; Xu G; Chen Z; Polemeropoulos A; Wang Z; Or YS
Bioorg Med Chem Lett; 2008 Dec; 18(24):6315-8. PubMed ID: 18996692
[TBL] [Abstract][Full Text] [Related]
20. Aleglitazar, a new, potent, and balanced dual PPARalpha/gamma agonist for the treatment of type II diabetes.
Bénardeau A; Benz J; Binggeli A; Blum D; Boehringer M; Grether U; Hilpert H; Kuhn B; Märki HP; Meyer M; Püntener K; Raab S; Ruf A; Schlatter D; Mohr P
Bioorg Med Chem Lett; 2009 May; 19(9):2468-73. PubMed ID: 19349176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
